Phenylephrine
Biorphen, IMMPHENTIV
alpha-1 Adrenergic Agonist
NADAC/unit
$8.7161
No Shortage
16 Manufacturers
49 ANDAs
vs. brand Biorphen: Generic saves up to 13% per unit
Market Intelligence
2024-01-03 Class II Recall: CARDINAL HEALTHCARE
Generic Manufacturers
ALCON RESEARCH LLCAMNEAL EU LTDASPIRO PHARMA LTDAVET LIFESCIENCES PRIVATE LTDBE PHARMACEUTICALS AGCAPLIN STERILES LTDDR REDDYS LABORATORIES SAEUGIA PHARMA SPECIALITIES LTDFRESENIUS KABI USA LLCGLAND PHARMA LTDHAINAN POLY PHARM CO LTDHIKMA PHARMACEUTICALS USA INCMANKIND PHARMA LTDMEITHEAL PHARMACEUTICALS INCMILLA PHARMACEUTICALS INCPARAGON BIOTECK INCPH HEALTH LTDSAGENT PHARMACEUTICALS INCSANDOZ INCSOMERSET THERAPEUTICS LLC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.